Global Med Technologies(R), Inc. to Present at the Noble Financial MAD MAX Equity Conference
August 07 2008 - 10:00AM
PR Newswire (US)
DENVER, Aug. 7 /PRNewswire-FirstCall/ -- Global Med
Technologies(R), Inc. ("Global Med" or the "Company") (OTC:GLOB)
(BULLETIN BOARD: GLOB) , an international e-Health, medical
information technology company, today announced that it will
present at the Fourth Annual Noble Financial Equity Conference at
12:30 p.m. (Pacific) on Monday, August 18, 2008 at the Loews Lake
Las Vegas Resort, Nevada, in the Road Warrior Room. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Dr.
Mick Ruxin, Chairman and CEO of Global Med, will give a
presentation regarding the Company's market positioning, financial
performance and strategic direction. Dr. Ruxin will also discuss
the recent European acquisition of Inlog, SA, and the U.S.
acquisition of eDonor(R). The presentation will be webcast LIVE
featuring high-definition, streaming video and PowerPoint slides.
Access is available by logging on to the conference website
http://www.noblemadmax.com/. It is recommended that interested
parties register at least 15 minutes prior to the start of the
presentation to ensure timely access. About Noble Financial Noble
Financial is a privately-held, full-service capital markets firm
driven by what is often overlooked by other firms -- uncovering the
value embedded in the orphaned, undiscovered or misunderstood
company. The company focuses on converting market inefficiencies
into profit opportunities. Noble Financial supports emerging
companies through strategic advice, investment banking,
market-making, sales & trading, comprehensive equity research,
and the development of institutional support. Noble Financial's
equity conferences -- 2008 marks their fourth annual -- allow for a
unique blend of professional and personal interaction among a
diverse cross-section of executives. The company has operated for
24 years and has offices in Florida, New York City and Boston.
About Global Med Technologies, Inc. Global Med Technologies(R),
Inc. is an international medical software company which develops
regulated and non-regulated software products and services for the
healthcare industry. As a leading provider of blood and laboratory
software applications and services, Global Med's products are
deployed in 20 countries and serve over 1,400 transfusion centers,
blood banks and laboratories. Global Med's U.S. division, Wyndgate
Technologies(R), provides Vein-to-Vein(R) tracking through its
Donor Doc(TM), SafeTrace(R), SafeTrace Tx(R) and ElDorado Donor(TM)
software products. Each year, Wyndgate's products and services
manage more than eight million blood components, representing over
27% of the U.S. blood supply. Global Med's European subsidiary,
Inlog, SA, is a leading provider of donor center and transfusion
management systems as well as cellular therapy software, laboratory
information systems and quality assurance medical software systems
internationally. Inlog's products include EdgeBlood**, EdgeTrack**,
EdgeCell, EdgeLab and SAPA. Global Med's U.S. division, eDonor(R),
provides a web-based donor relationship management system that
integrates recruitment, scheduling, retention and fulfillment for
national as well as local community blood centers and hospitals.
eDonor's products and services are designed to complement Global
Med's strong line of international blood management and laboratory
information software and service solutions. Global Med's U.S.
subsidiary, PeopleMed(R), Inc., provides cost-effective customized
software validation, consulting and compliance solutions to
hospitals and donor centers. For more information about Global
Med's products and services, please call 800-996-3428 or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/,
http://www.inlog.com/ and http://www.wyndgate.com/. **FDA 510(k)
clearance required prior to sales in the U.S. This news release may
include statements that constitute forward-looking statements,
usually containing the words "believe," "estimate," "project,"
"expects" or similar expressions. These statements are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements
inherently involve risks and uncertainties that could cause actual
results to differ materially from the forward-looking statements.
By making these forward-looking statements, the Company undertakes
no obligation to update these statements for revisions or changes
after the date of this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000, ; or investors, Paul Holm, President,
portfolio pr, +1-212-888-4570, , for Global Med Technologies, Inc.
Web site: http://www.globalmedtech.com/ http://www.noblemadmax.com/
Copyright